Research method
A claim-checking checklist for peptide research
Peptide claims often become broader as they move from a paper to social copy. This checklist helps readers return each statement to the evidence type, population, and outcome that actually support it.
Educational content only. Not medical advice.
Define exactly what the claim promises
Underline the subject, action, outcome, population, and certainty word. 'Compound X changed a signaling marker in mouse tissue' is a different claim from 'Compound X improves recovery in people.' Words such as proves, reverses, heals, safe, and works for everyone require evidence that is rarely supplied by a single early study.
Classify the statement as chemistry, mechanism, association, efficacy, safety, approval, or practical-use guidance. Each category has a different source of truth. A receptor-binding paper cannot establish regulatory approval, and a regulator label does not prove every off-label mechanism discussed online.
Match the evidence level to the sentence
Identify whether the source is a biochemical experiment, cell study, animal model, case report, observational analysis, controlled human trial, systematic review, registry entry, or regulator document. Preserve that label in the public explanation. Preclinical findings can be scientifically important while still being insufficient to predict human benefit or risk.
Check the comparator, sample size, duration, endpoint, and confidence interval where applicable. Statistical significance does not automatically mean the effect is large, clinically meaningful, durable, or applicable to a different population.
Check population, outcome, and development status
Ask who or what was studied and who was excluded. Results in adults with a defined condition do not automatically apply to healthy people, adolescents, older adults, or people taking other therapies. Surrogate biomarkers should be named as surrogate biomarkers rather than converted into guaranteed health outcomes.
For development and approval claims, use official regulator and registry sources dated to the review. 'Investigational,' 'registered in a trial,' and 'approved for a defined indication' are not interchangeable. Approval status can also vary by country and formulation.
Publish the uncertainty, not just the finding
A defensible summary states what the source supports, its important limitations, and what remains unknown. Include conflicting or null evidence when it materially changes the picture. Do not hide adverse events, discontinuations, missing data, short follow-up, or sponsor involvement; report them proportionally alongside study strengths.
Finish with a source note that connects every material statement to a primary or official reference. If the available evidence cannot support a bounded educational claim, do not publish the claim. A transparent 'not established' is more useful than filling the gap with anecdotes or vendor copy.
Evidence limits
- A checklist improves consistency but does not replace subject-matter review of complex or conflicting evidence.
- Regulatory status and study records can change, so date-sensitive claims require a fresh official check before publication.
- The page does not assess products, vendors, personal treatment decisions, dosage, or administration.
Sources and further reading
These sources ground the definitions and evidence boundaries on this page. A citation is a route for verification, not an endorsement of a product or personal use.
U.S. Food and Drug Administration
Drug Development Process
Official overview of discovery, preclinical work, clinical research, review, and post-market monitoring.
Open sourceMedlinePlus, National Library of Medicine
Evaluating Health Information
Public framework for checking evidence, authorship, purpose, currency, and source quality.
Open sourceU.S. National Library of Medicine
ClinicalTrials.gov Glossary Terms
Definitions that prevent registry status and outcome fields from being misreported.
Open sourceCommon questions
Does animal evidence mean a peptide does not work in humans?
No. It means the human outcome is not established by that evidence alone. Animal research can support hypotheses and development decisions while leaving translation uncertain.
Is a systematic review always the best source?
It can provide a valuable synthesis, but quality depends on its question, search, included studies, bias assessment, and currency. Primary and official sources may still be needed for specific claims.
Continue with context
Continue in the PeptideSchool workspace
Use the member workspace to organize references, compare research notes, and explore the complete peptide library. Protocol, dosage, and reconstitution material remains inside the appropriate Premium context.